Patent application number | Description | Published |
20090110688 | COMBINATION THERAPY OF TYPE II ANTI-CD20 ANTIBODY WITH A PROTEASOME INHIBITOR - The present invention is directed to a combination therapy involving a type II anti-CD20 antibody and a proteasome inhibitor for the treatment of a patient suffering from cancer, particularly a CD20-expressing cancer. | 04-30-2009 |
20090191187 | ANTIBODIES AGAINST INTERLEUKIN-1 RECEPTOR AND USES THEREOF - The present invention relates to antibodies against interleukin-1 receptor (IL-1R), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof. The antibodies of the present invention are particularly useful for treating a variety of inflammatory diseases including, but not limited to, rheumatoid arthritis. | 07-30-2009 |
20100247484 | COMBINATION THERAPY OF AN AFUCOSYLATED ANTIBODY AND ONE OR MORE OF THE CYTOKINES GM CSF, M CSF AND/OR IL3 - The present invention is directed to the combination therapy of an afucosylated antibody specifically binding to a tumor-antigen with one or more cytokines selected from the group of human GM-CSF, human M-CSF and/or human IL-3 for the treatment of cancer. | 09-30-2010 |
20110070246 | Antibodies Against CDCP1 for the Treatment of Cancer - The present invention relates to antibodies against human CDCP1 binding to the same epitope as CUB4 (Deposition No. DSM ACC2551) for the treatment of cancer. | 03-24-2011 |
20110165156 | ANTIBODIES AGAINST HUMAN CSF-1R AND USES THEREOF - The present invention relates to antibodies against human CSF-1R (anti-CSF-1R antibody), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof. | 07-07-2011 |
20110200598 | COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A PROTEASOME INHIBITOR - The present invention is directed to a combination therapy involving a type II anti-CD20 antibody and a proteasome inhibitor for the treatment of a patient suffering from cancer, particularly a CD20-expressing cancer. An aspect of the invention is a composition comprising a type II anti-CD20 antibody and a proteasome inhibitor. Another aspect of the invention is a kit comprising a type II anti-CD20 antibody and a proteasome inhibitor. Yet another aspect of the invention is a method for the treatment of a patient suffering from cancer comprising co-administering, to a patient in need of such treatment, a type II anti-CD20 antibody and a proteasome inhibitor. | 08-18-2011 |
20120213774 | Antibodies against human IL33R and uses thereof - An antibody binding to IL33R characterized in that the heavy chain variable domain comprises a CDR3 region of SEQ ID NO:1, a CDR2 region of SEQ ID NO:2 and a CDR1 region of SEQ ID NO:3 and in that the light chain variable domain comprises a CDR3 region of SEQ ID NO:4, a CDR2 region of SEQ ID NO:5 and a CDR1 region of SEQ ID NO:6 or a chimeric, humanized or T cell epitope depleted antibody variant thereof has advantageous properties for the treatment of inflammatory diseases. | 08-23-2012 |
20120219549 | Combination therapy of a type II anti-CD20 antibody with a proteasome inhibitor - The present invention is directed to a combination therapy involving a type II anti-CD20 antibody and a proteasome inhibitor for the treatment of a patient suffering from cancer, particularly a CD20-expressing cancer. An aspect of the invention is a composition comprising a type II anti-CD20 antibody and a proteasome inhibitor. Another aspect of the invention is a kit comprising a type II anti-CD20 antibody and a proteasome inhibitor. Yet another aspect of the invention is a method for the treatment of a patient suffering from cancer comprising co-administering, to a patient in need of such treatment, a type II anti-CD20 antibody and a proteasome inhibitor. | 08-30-2012 |
20120329997 | ANTIBODIES AGAINST HUMAN CSF-1R AND USES THEREOF - The present invention relates to antibodies against human CSF-1R (CSF-1R antibody), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof. | 12-27-2012 |
20130005949 | ANTIBODIES AGAINST HUMAN CSF-1R AND USES THEREOF - The present invention relates to antibodies against human CSF-1R (CSF-1R antibody), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof. | 01-03-2013 |
20140302015 | ANTIBODIES AGAINST HUMAN IL33R AND USES THEREOF - An antibody binding to IL33R characterized in that the heavy chain variable domain comprises a CDR3 region of SEQ ID NO:1, a CDR2 region of SEQ ID NO:2 and a CDR1 region of SEQ ID NO:3 and in that the light chain variable domain comprises a CDR3 region of SEQ ID NO:4, a CDR2 region of SEQ ID NO:5 and a CDR1 region of SEQ ID NO:6 or a a chimeric, humanized or T cell epitope depleted antibody variant thereof has advantageous properties for the treatment of inflammatory diseases. | 10-09-2014 |
20140336363 | ANTIBODIES AGAINST HUMAN CSF-1R AND USES THEREOF - The present invention relates to antibodies against human CSF-1R (CSF-1R antibody), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof. | 11-13-2014 |
20150080556 | ANTIBODIES AGAINST HUMAN CSF-1R AND USES THEREOF - The present invention relates to antibodies against human CSF-1R (CSF-1R antibody), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof. | 03-19-2015 |
Patent application number | Description | Published |
20080320216 | Translation Lookaside Buffer and Related Method and Program Product Utilized For Virtual Addresses - A program product, a translation lookaside buffer and a related method for operating the TLB is provided. The method comprises the steps of: a) when adding an entry for a virtual address to said TLB testing whether the attribute data of said virtual address is already stored in said CAM and if the attribute data is not stored already in said CAM, generating tag data for said virtual address such that said tag data is different from the tag data generated for the other virtual addresses currently stored in said RAM and associated to the new entry in said CAM for the attribute data, adding the generated tag data to said RAM and to the associated entry in said CAM, and setting a validity flag in said CAM for said associated entry; else if the attribute data is stored already in said CAM, adding the stored attribute data to the entry in said RAM for said virtual address; and when performing a TLB lookup operation: reading the validity flag and the tag data from the entry in said CAM, which is associated to the entry in said RAM for said virtual address, and simultaneously reading the absolute address and the tag data from the entry in said RAM for said virtual address, and generating a TLB hit only if the tag data read from said CAM is valid and matches the tag data read from said RAM. | 12-25-2008 |
20090140362 | PHOTO DETECTOR - A photo detector comprising a grating (PC). The grating (PC) is arranged on top of a surface of an active semiconductor layer. The grating (PC) is patterned in uninterrupted first strips (ST | 06-04-2009 |
20100122221 | METHOD AND APPARATUS FOR DESIGNING A DEVICE FOR ELECTRO-OPTICAL MODULATION OF LIGHT INCIDENT UPON THE DEVICE - A method and apparatus for designing a device to operate in a coupling mode, a detection mode, or a reflection mode for incident light. The incident light has a wavelength λ and is incident upon a semiconductor structure of the device at an angle of incidence (θ | 05-13-2010 |
20100161867 | SYSTEM AND METHOD FOR DISTRIBUTING SIGNAL WITH EFFICIENCY OVER MICROPROCESSOR - A system and associated method for distributing signals with efficiency over a microprocessor. A performance monitoring unit (PMU) sends configuration signals to a unit to monitor an event occurring on the unit. The unit is attached to a configuration bus and an event bus that are daisy-chained from PMU to other units in the microprocessor. The configuration bus transmits configuration signals from the PMU to the unit to set the unit to report the event. The unit sends event signals to the PMU through the event bus. The unit is configured upon receiving configuration signals comprising a base address of a bus ramp of the unit. A number of units and a number of events for monitoring is flexibly selected by adjusting a length of bit fields within configuration signals. | 06-24-2010 |
20120246608 | DEVICE FOR ELECTRO-OPTICAL MODULATION OF LIGHT INCIDENT UPON THE DEVICE - A method and apparatus for designing a device to operate in a coupling mode, a detection mode, or a reflection mode for incident light. The incident light has a wavelength λ and is incident upon a semiconductor structure of the device at an angle of incidence (θ | 09-27-2012 |